GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 30 Sep 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $71.77. Bristol-Myers Squibb Co. fell$. 53 or 1.0 percent, to $51.18. Hospira fell$. 72 or 1.4 percent, to $52.03.

  • Midday Glance: Pharmaceuticals companies Tuesday, 30 Sep 2014 | 1:20 PM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $71.79. Bristol-Myers Squibb Co. fell$. 32 or. 6 percent, to $51.39. Hospira fell$. 45 or. 9 percent, to $52.30.

  • Early Glance: Pharmaceuticals companies Tuesday, 30 Sep 2014 | 10:40 AM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $71.53. Bristol-Myers Squibb Co. fell$. 37 or. 7 percent, to $51.34. Hospira fell$. 39 or. 7 percent, to $52.36.

  • MADRID, Sept 30- A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects-- but their high cost is a growing concern. Price-- just as much as safety and efficacy-- has proved a hot topic for nearly 20,000 oncology experts at the European Society for Medical Oncology annual congress in Madrid.

  • Final Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 40 or. 6 percent, to $71.88. Bristol-Myers Squibb Co. rose$. 61 or 1.2 percent, to $51.71. Hospira rose$. 54 or 1.0 percent, to $52.75.

  • Midday Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 1:51 PM ET

    Baxter International Inc. fell$. 41 or. 6 percent, to $71.87. Bristol-Myers Squibb Co. rose$. 61 or 1.2 percent, to $51.71. Hospira rose$. 24 or. 5 percent, to $52.45.

  • Early Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 10:36 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $71.92. Hospira fell$. 25 or. 5 percent, to $51.96. Johnson& Johnson fell$. 94 or. 9 percent, to $106.16.

  • MADRID, Sept 28- Merck& Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system suggest the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Midday Glance: Pharmaceuticals companies Friday, 26 Sep 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 75 or 1.1 percent, to $72.03. Bristol-Myers Squibb Co. fell$. 79 or 1.5 percent, to $50.83. Hospira fell$. 03 or. 1 percent, to $52.00.

  • Early Glance: Pharmaceuticals companies Friday, 26 Sep 2014 | 11:12 AM ET

    Baxter International Inc. rose$. 86 or 1.2 percent, to $72.14. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $51.50. Johnson& Johnson fell$. 13 or. 1 percent, to $106.98.

  • Final Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 88 or 1.2 percent, to $71.28. Bristol-Myers Squibb Co. fell$. 34 or. 7 percent, to $51.62. Hospira fell $1.01 or 1.9 percent, to $52.03.

  • Midday Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 1:24 PM ET

    Baxter International Inc. fell$. 80 or 1.1 percent, to $71.36. Bristol-Myers Squibb Co. fell$. 37 or. 7 percent, to $51.59. Hospira fell$. 89 or 1.7 percent, to $52.15.

  • Early Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 11:40 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $71.66. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.86. Hospira fell$. 33 or. 6 percent, to $52.71.

  • Final Glance: Pharmaceuticals companies Wednesday, 24 Sep 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 44 or. 6 percent, to $72.16. Bristol-Myers Squibb Co. rose$. 67 or 1.3 percent, to $51.96. Hospira rose$. 90 or 1.7 percent, to $53.04.

  • Midday Glance: Pharmaceuticals companies Wednesday, 24 Sep 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 28 or. 4 percent, to $72.00. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $51.59. Hospira rose$. 40 or. 8 percent, to $52.54.

  • Early Glance: Pharmaceuticals companies Wednesday, 24 Sep 2014 | 10:33 AM ET

    Baxter International Inc. rose$. 02 or percent, to $71.74. Bristol-Myers Squibb Co. rose$. 26 or. 5 percent, to $51.55. Hospira rose$. 04 or. 1 percent, to $52.18.

  • Final Glance: Pharmaceuticals companies Tuesday, 23 Sep 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $71.72. Bristol-Myers Squibb Co. fell$. 38 or. 7 percent, to $51.29. Eli Lilly& Co. fell$. 13 or. 2 percent, to $65.95.

  • Midday Glance: Pharmaceuticals companies Tuesday, 23 Sep 2014 | 1:20 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.68. Bristol-Myers Squibb Co. fell$. 34 or. 7 percent, to $51.33. Hospira fell$. 28 or. 5 percent, to $52.18.